We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Guidance on Presubmission Program Gives Tips on Study Risk-Determination Requests
FDA Guidance on Presubmission Program Gives Tips on Study Risk-Determination Requests
Devicemakers planning a PMA or product development protocol should take advantage of presubmission determination meetings with the FDA to pin down exactly what data the agency expects to support safety and efficacy of a new product.